Skip to content

Effect of "Instructional Functional Electrical Stimulation Machine" on early rehabilitation of motor function after cerebral infarction

New technique developments for the rehabilitation of cerebral vascular diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001159
Enrollment
Unknown
Registered
2010-11-17
Start date
2010-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

A:conventional rehabilitation training + instructional functional electrical stimulation (placebo
Monday to Friday: 20 minutes per day, for 8 weeks)
B:conventional rehabilitation training + instructional functional electrical stimulation (Monday to Friday: 20 minutes per day, for 8 weeks)

Sponsors

Ministry of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 40 and 80 years old; (2) First onset of cerebral hemorrhage or cerebral infarction; or previous lacunar cerebral infarction without sequelae; (3) In accordance with the diagnosis criteria released in the 4th National Conference on Cerebral Vascular Diseases in 1995; (4) Confirmed by CT or MRI; (5) Onset of the disease between 3 and 14 days, with limbs dysfunction; (6) Brunnstrom scale of affected limbs: stage 1; (7) Receive no standard rehabilitation therapy before the study; (8) Sign informed consent forms.

Exclusion criteria

Exclusion criteria: (1) With presentation of consciousness disturbances, or with dementia according to MMSE scale, combined with sensory aphasia and psychic disorders that cannot cooperate; (2) Comorbidities with severe primary diseases of heart, liver, kidney and hematological system; (3) Combined with motor dysfunction caused by osteoarthritis diseases; (4) History of cognitive disorders, psychic disorders and drugs or alcohol abuse; (5) Combined with primary organs dysfunction and critically ill patients; or combined with other diseases that might cause more influences the quality of life than the limbs dysfunction after stroke, such as cancer; (6) Patients with cardiac pacemakers; (7) Patients with poor compliance or not suitable for follow-ups; (8) Skin infections or lesions on forearms and legs; (9) With ulcers or diseases that have a tendency to hemorrhage

Design outcomes

Primary

MeasureTime frame
upper-limb MSS;

Secondary

MeasureTime frame
simplified Fugl-Meyer motor scale;

Countries

China

Contacts

Public ContactYi WU
shannonjj@126.com+86 021 52887819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026